TUCSON, Ariz., Sept. 12, 2016 -- Medicine is being “fundamentally transformed” into an unaffordable, complex, adversarial, depersonalized labyrinth, writes dermatologist Melinda Woofter, M.D., of Granville, Ohio, in the fall issue of the Journal of American Physicians and Surgeons. Dr. Woofter is currently president of the Association of American Physicians and Surgeons (AAPS).
The direct reason for the unsustainable system, she writes, is government distortion of the marketplace, destroying cost transparency: “Government control of resources always leads to less for everyone. Without natural price signals for market adjustments, costs soar as resources are wrongly allocated, wasted, and squandered.”
In an effort to fix the problem it caused, government resorts to further price controls and still more coercion and restrictions, she explains. Solutions are difficult to find because “government powerholders and third-party cronies who benefit from this will not give up their stranglehold on medicine.”
Dr. Woofter recommends a short new primer analyzing the causes of the high costs and deteriorating quality of American medicine: Common Sense Medicine: Restoring the Patient/Physician Relationship by Jeff Danby. The key is not to pass more laws and regulations, but to restore natural price discovery between patients and doctors, Danby writes.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail., or Melinda Woofter, M.D., [email protected]


Anta Sports Expands Global Footprint With Strategic Puma Stake
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
Samsung Electronics Shares Jump on HBM4 Mass Production Report 



